口腔粘膜炎の世界市場レポート 2025年

口腔粘膜炎市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.3％で20億8,000万米ドルに成長します。予測期間の成長は、世界のがん罹患率の上昇、個別化医療に対する需要の増加、緩和ケアへの注目の高まり、患者の意識と教育の改善、市販の口腔ケア製品の採用拡大、政府・ヘルスケア投資の増加、放射線・化学療法の普及率の上昇などに起因すると考えられます。この期間に予想される主な動向には、低レベルレーザー治療の発展、新規ドラッグデリバリーシステムの開発、デジタルヘルス技術の統合、治療計画における人工知能の採用、組織工学と再生療法の進歩、スマート洗口剤と口腔ケア製品の革新などがあります。

がんの有病率の上昇は、今後数年間の口腔粘膜炎市場の拡大を促進すると予想されます。がんは、正常組織に侵入して破壊する異常細胞の制御不能な増殖と拡散を特徴とする疾患です。がん患者数の増加には、高齢化、ライフスタイルの変化、環境暴露、感染症、遺伝的素因など、いくつかの要因が関与しています。口腔粘膜炎療法は、痛みを和らげ、炎症を抑え、二次感染を予防し、口腔組織の治癒を早めることで、がん患者をサポートする重要な役割を担っています。その結果、化学療法や放射線療法中の患者の快適性、栄養摂取、生活の質全体が向上します。例えば、2024年5月、米国の政府機関である国立がん研究所は、2022年に世界で約2,000万人のがん患者が新たに発生し、970万人ががんに関連して死亡したと報告しました。予測では、この数字は2040年までに年間2,990万人が新たにがんを発症し、1,530万人が死亡するとされています。その結果、がんの有病率の増加が口腔粘膜炎市場の成長に拍車をかけています。

口腔粘膜炎市場の主要企業は、口腔組織へのダメージを最小限に抑えるために寒冷療法を使用することで、症状の重症度や発生率を低下させるため、凍結療法などの革新的な治療ソリューションに注力しています。凍結療法は、極寒を利用して異常組織や病変組織を凍結・除去する治療法であり、イボや腫瘍、ケガなどの治療に一般的に用いられています。例えば、2024年2月、米国の医療機器会社であるChemo Mouthpiece LLCは、同社のケモ・マウスピース・デバイスが米国の政府機関である食品医薬品局（FDA）から承認を受けたと発表しました。この口腔内アイスパックは、化学療法患者の口腔内に凍結療法を提供し、がん治療の副作用として頻発し苦痛を伴う口腔粘膜炎を積極的に管理・治療します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界口腔粘膜炎PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の口腔粘膜炎市場：成長率分析
• 世界の口腔粘膜炎市場の実績：規模と成長, 2019-2024
• 世界の口腔粘膜炎市場の予測：規模と成長, 2024-2029, 2034F
• 世界口腔粘膜炎総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の口腔粘膜炎市場：適応症別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 化学療法
• 放射線療法
• 造血幹細胞移植
• 世界の口腔粘膜炎市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 固形剤形
• 液体剤形
• 世界の口腔粘膜炎市場治療別、実績と予測, 2019-2024, 2024-2029F, 2034F
• パリフェルミン
• アミフォスチン
• クロルヘキシジン
• スクラルファート
• アバソパセム
• 夕暮れ
• 世界の口腔粘膜炎市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界の口腔粘膜炎市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 歯科医院
• 腫瘍学病院
• 調査機関
• 世界の口腔粘膜炎市場化学療法の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 高用量化学療法誘発性口腔粘膜炎
• 標準用量化学療法誘発性口腔粘膜炎
• 世界の口腔粘膜炎市場放射線治療の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 頭頸部がんの放射線治療誘発性口腔粘膜炎
• 全身照射誘発性口腔粘膜炎
• 世界の口腔粘膜炎市場造血幹細胞移植の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 自家幹細胞移植誘発性口腔粘膜炎
• 同種幹細胞移植誘発性口腔粘膜炎

第7章 地域別・国別分析

• 世界の口腔粘膜炎市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の口腔粘膜炎市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 口腔粘膜炎市場：競合情勢
• 口腔粘膜炎市場：企業プロファイル
  • Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Mundipharma International Limited Overview, Products and Services, Strategy and Financial Analysis
  • Swedish Orphan Biovitrum Overview, Products and Services, Strategy and Financial Analysis
  • EUSA Pharma Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Galera Therapeutics Inc.
• Enzychem Lifesciences Corporation
• Oragenics Inc.
• Soligenix Inc.
• Jaguar Health Inc.
• Monopar Therapeutics Inc.
• EpicentRx
• BrainCool
• Cellceutix Corporation
• GlycoMira Therapeutics Inc.
• Innovation Pharmaceuticals Inc.
• Allander Biotechnologies
• Aurora BioScience
• Solasia Pharma KK
• NeoMedLight

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 口腔粘膜炎市場2029：新たな機会を提供する国
• 口腔粘膜炎市場2029：新たな機会を提供するセグメント
• 口腔粘膜炎市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Oral mucositis is a condition characterized by inflammation and ulceration of the mucous membranes lining the mouth. It commonly occurs as a side effect of cancer treatments, particularly chemotherapy and radiation therapy, which damage the rapidly dividing cells of the oral mucosa.

The primary indications for oral mucositis include chemotherapy, radiotherapy, and hematopoietic stem cell transplantation. Chemotherapy-induced oral mucositis arises when chemotherapy drugs damage the rapidly dividing cells in the mouth's lining, leading to painful ulcers and inflammation. Available products come in solid and liquid dosage forms, with treatment options including palifermin, amifostine, chlorhexidine, sucralfate, avasopasem, and dusquetide. These treatments are distributed through hospital pharmacies, retail pharmacies, and online pharmacies and are utilized by various end-users, such as hospitals, dental clinics, oncology hospitals, and research institutes.

The oral mucositis market research report is one of a series of new reports from The Business Research Company that provides oral mucositis market statistics, including the oral mucositis industry's global market size, regional shares, competitors with an oral mucositis market share, detailed oral mucositis market segments, market trends and opportunities, and any further data you may need to thrive in the oral mucositis industry. This oral mucositis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The oral mucositis market size has grown strongly in recent years. It will grow from $1.51 billion in 2024 to $1.63 billion in 2025 at a compound annual growth rate (CAGR) of 8.0%. The growth during the historic period can be attributed to the increase in cancer cases, the rise in chemotherapy and radiation treatments, growing awareness of oral mucositis, increased adoption of supportive care therapies, a higher incidence of head and neck cancers, and the rise in research and development in oncology supportive care.

The oral mucositis market size is expected to see strong growth in the next few years. It will grow to $2.08 billion in 2029 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to the rising global incidence of cancer, increasing demand for personalized medicine, a growing focus on palliative care, improved patient awareness and education, greater adoption of over-the-counter oral care products, increasing government and healthcare investments, and the rising prevalence of radiation and chemotherapy treatments. Key trends expected during this period include advancements in low-level laser therapy, the development of novel drug delivery systems, the integration of digital health technologies, the adoption of artificial intelligence in treatment planning, progress in tissue engineering and regenerative therapies, and innovations in smart mouthwashes and oral care products.

The rising prevalence of cancer is expected to drive the expansion of the oral mucositis market in the coming years. Cancer is a disease characterized by the uncontrolled growth and spread of abnormal cells, which can invade and destroy normal tissues. Several factors contribute to the increasing number of cancer cases, including an aging population, lifestyle changes, environmental exposure, infections, and genetic predisposition. Oral mucositis therapy plays a crucial role in supporting cancer patients by alleviating pain, reducing inflammation, preventing secondary infections, and promoting the faster healing of oral tissues. This ultimately enhances their comfort, nutritional intake, and overall quality of life during chemotherapy or radiation therapy. For example, in May 2024, the National Cancer Institute, a US-based government agency, reported that approximately 20 million new cancer cases and 9.7 million cancer-related deaths occurred worldwide in 2022. Projections indicate that these figures could rise to 29.9 million new cases and 15.3 million deaths annually by 2040. Consequently, the increasing prevalence of cancer is fueling the growth of the oral mucositis market.

Leading companies in the oral mucositis market are focusing on innovative treatment solutions, such as cryotherapy, to reduce the severity and incidence of the condition by using cold therapy to minimize damage to oral tissues. Cryotherapy is a medical treatment that utilizes extreme cold to freeze and eliminate abnormal or diseased tissue and is commonly used to treat conditions such as warts, tumors, or injuries. For instance, in February 2024, Chemo Mouthpiece LLC, a US-based medical device company, announced that its chemo mouthpiece device received approval from the Food and Drug Administration, a US-based government agency. This intraoral ice pack delivers cryotherapy to the oral cavity of chemotherapy patients, proactively managing and treating oral mucositis, a frequent and painful side effect of cancer treatment.

In July 2022, Solasia Pharma K.K., a Japan-based biotechnology company, acquired the episil oral liquid business from Camurus AB for an undisclosed amount. This acquisition aims to strengthen Solasia Pharma K.K.'s oncology and supportive care portfolio by leveraging Camurus AB's proprietary drug delivery technologies and innovative treatments. The deal enhances Solasia Pharma K.K.'s ability to develop and commercialize advanced therapeutics for cancer patients. Camurus AB is a Sweden-based company specializing in oral mucositis drugs.

Major players in the oral mucositis market are Merck & Co Inc., Amgen Inc., Mundipharma International Limited, Swedish Orphan Biovitrum, EUSA Pharma, Galera Therapeutics Inc., Enzychem Lifesciences Corporation, Oragenics Inc., Soligenix Inc., Jaguar Health Inc., Monopar Therapeutics Inc., EpicentRx, BrainCool, Cellceutix Corporation, GlycoMira Therapeutics Inc., Innovation Pharmaceuticals Inc., Allander Biotechnologies, Aurora BioScience, Solasia Pharma KK, NeoMedLight, MuReva (Lumitex), Prothex Pharmaceuticals Inc.

North America was the largest region in the oral mucositis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in oral mucositis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the oral mucositis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The oral mucositis market consists of revenues earned by entities by providing services such as low-level laser therapy, nutritional support, and cryotherapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The oral mucositis market also includes sales of mouthwashes and rinses, gels, sprays, or films, topical analgesics and anesthetics, and anti-inflammatory agents. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Oral Mucositis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on oral mucositis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for oral mucositis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The oral mucositis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Indication: Chemotherapy; Radiotherapy; Hematopoietic Stem Cell Transplantation
• 2) By Product Type: Solid Dosage Form; Liquid Dosage Form
• 3) By Treatment: Palifermin; Amifostine; Chlorhexidine; Sucralfate; Avasopasem; Dusquetide
• 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• 5) By End User: Hospitals; Dental Clinics; Oncology Hospitals; Research Institutes
• Subsegments:
• 1) By Chemotherapy: High-Dose Chemotherapy-Induced Oral Mucositis; Standard-Dose Chemotherapy-Induced Oral Mucositis
• 2) By Radiotherapy: Head And Neck Cancer Radiotherapy-Induced Oral Mucositis; Total Body Irradiation-Induced Oral Mucositis
• 3) By Hematopoietic Stem Cell Transplantation: Autologous Stem Cell Transplantation-Induced Oral Mucositis; Allogeneic Stem Cell Transplantation-Induced Oral Mucositis
• Companies Mentioned: Merck & Co Inc.; Amgen Inc.; Mundipharma International Limited; Swedish Orphan Biovitrum; EUSA Pharma
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Oral Mucositis Market Characteristics

3. Oral Mucositis Market Trends And Strategies

4. Oral Mucositis Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Oral Mucositis Growth Analysis And Strategic Analysis Framework

• 5.1. Global Oral Mucositis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Oral Mucositis Market Growth Rate Analysis
• 5.4. Global Oral Mucositis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Oral Mucositis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Oral Mucositis Total Addressable Market (TAM)

6. Oral Mucositis Market Segmentation

• 6.1. Global Oral Mucositis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chemotherapy
• Radiotherapy
• Hematopoietic Stem Cell Transplantation
• 6.2. Global Oral Mucositis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Solid Dosage Form
• Liquid Dosage Form
• 6.3. Global Oral Mucositis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Palifermin
• Amifostine
• Chlorhexidine
• Sucralfate
• Avasopasem
• Dusquetide
• 6.4. Global Oral Mucositis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.5. Global Oral Mucositis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Dental Clinics
• Oncology Hospitals
• Research Institutes
• 6.6. Global Oral Mucositis Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• High-Dose Chemotherapy-Induced Oral Mucositis
• Standard-Dose Chemotherapy-Induced Oral Mucositis
• 6.7. Global Oral Mucositis Market, Sub-Segmentation Of Radiotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Head And Neck Cancer Radiotherapy-Induced Oral Mucositis
• Total Body Irradiation-Induced Oral Mucositis
• 6.8. Global Oral Mucositis Market, Sub-Segmentation Of Hematopoietic Stem Cell Transplantation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Autologous Stem Cell Transplantation-Induced Oral Mucositis
• Allogeneic Stem Cell Transplantation-Induced Oral Mucositis

7. Oral Mucositis Market Regional And Country Analysis

• 7.1. Global Oral Mucositis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Oral Mucositis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Oral Mucositis Market

• 8.1. Asia-Pacific Oral Mucositis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Oral Mucositis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Oral Mucositis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Oral Mucositis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Oral Mucositis Market

• 9.1. China Oral Mucositis Market Overview
• 9.2. China Oral Mucositis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Oral Mucositis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Oral Mucositis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Oral Mucositis Market

• 10.1. India Oral Mucositis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Oral Mucositis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Oral Mucositis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Oral Mucositis Market

• 11.1. Japan Oral Mucositis Market Overview
• 11.2. Japan Oral Mucositis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Oral Mucositis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Oral Mucositis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Oral Mucositis Market

• 12.1. Australia Oral Mucositis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Oral Mucositis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Oral Mucositis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Oral Mucositis Market

• 13.1. Indonesia Oral Mucositis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Oral Mucositis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Oral Mucositis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Oral Mucositis Market

• 14.1. South Korea Oral Mucositis Market Overview
• 14.2. South Korea Oral Mucositis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Oral Mucositis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Oral Mucositis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Oral Mucositis Market

• 15.1. Western Europe Oral Mucositis Market Overview
• 15.2. Western Europe Oral Mucositis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Oral Mucositis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Oral Mucositis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Oral Mucositis Market

• 16.1. UK Oral Mucositis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Oral Mucositis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Oral Mucositis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Oral Mucositis Market

• 17.1. Germany Oral Mucositis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Oral Mucositis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Oral Mucositis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Oral Mucositis Market

• 18.1. France Oral Mucositis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Oral Mucositis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Oral Mucositis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Oral Mucositis Market

• 19.1. Italy Oral Mucositis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Oral Mucositis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Oral Mucositis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Oral Mucositis Market

• 20.1. Spain Oral Mucositis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Oral Mucositis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Oral Mucositis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Oral Mucositis Market

• 21.1. Eastern Europe Oral Mucositis Market Overview
• 21.2. Eastern Europe Oral Mucositis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Oral Mucositis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Oral Mucositis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Oral Mucositis Market

• 22.1. Russia Oral Mucositis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Oral Mucositis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Oral Mucositis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Oral Mucositis Market

• 23.1. North America Oral Mucositis Market Overview
• 23.2. North America Oral Mucositis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Oral Mucositis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Oral Mucositis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Oral Mucositis Market

• 24.1. USA Oral Mucositis Market Overview
• 24.2. USA Oral Mucositis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Oral Mucositis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Oral Mucositis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Oral Mucositis Market

• 25.1. Canada Oral Mucositis Market Overview
• 25.2. Canada Oral Mucositis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Oral Mucositis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Oral Mucositis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Oral Mucositis Market

• 26.1. South America Oral Mucositis Market Overview
• 26.2. South America Oral Mucositis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Oral Mucositis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Oral Mucositis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Oral Mucositis Market

• 27.1. Brazil Oral Mucositis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Oral Mucositis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Oral Mucositis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Oral Mucositis Market

• 28.1. Middle East Oral Mucositis Market Overview
• 28.2. Middle East Oral Mucositis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Oral Mucositis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Oral Mucositis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Oral Mucositis Market

• 29.1. Africa Oral Mucositis Market Overview
• 29.2. Africa Oral Mucositis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Oral Mucositis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Oral Mucositis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Oral Mucositis Market Competitive Landscape And Company Profiles

• 30.1. Oral Mucositis Market Competitive Landscape
• 30.2. Oral Mucositis Market Company Profiles
  • 30.2.1. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Mundipharma International Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Swedish Orphan Biovitrum Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. EUSA Pharma Overview, Products and Services, Strategy and Financial Analysis

31. Oral Mucositis Market Other Major And Innovative Companies

• 31.1. Galera Therapeutics Inc.
• 31.2. Enzychem Lifesciences Corporation
• 31.3. Oragenics Inc.
• 31.4. Soligenix Inc.
• 31.5. Jaguar Health Inc.
• 31.6. Monopar Therapeutics Inc.
• 31.7. EpicentRx
• 31.8. BrainCool
• 31.9. Cellceutix Corporation
• 31.10. GlycoMira Therapeutics Inc.
• 31.11. Innovation Pharmaceuticals Inc.
• 31.12. Allander Biotechnologies
• 31.13. Aurora BioScience
• 31.14. Solasia Pharma KK
• 31.15. NeoMedLight

32. Global Oral Mucositis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Oral Mucositis Market

34. Recent Developments In The Oral Mucositis Market

35. Oral Mucositis Market High Potential Countries, Segments and Strategies

• 35.1 Oral Mucositis Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Oral Mucositis Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Oral Mucositis Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer